SYN1 and Alzheimer disease: Interestingly, our findings demonstrate a strong affinity of RA towards both BACE1 and synapsin I. Therefore, we postulated RA as a promising agent that can suppress abnormal Aβ production by targeting BACE1 and synapsins in AD, however, further in vivo and in vitro studies on the molecular interactions are warranted.